Press release
Cancer Biomarkers Market Anticipated to Exceed USD 74.3 Billion by 2035
Cancer Biomarkers Market Anticipated to Exceed USD 74.3 Billion by 2035
MarketGenics, a global research and consulting firm, today announced its latest report on the Cancer Biomarkers Market, highlighting how early detection, liquid biopsy innovations, and AI-enabled diagnostics are driving the future of oncology care.
Get the complete market breakdown - statistics, insights, and future outlook: https://marketgenics.co/reports/cancer-biomarkers-market-00931
Market Outlook
The global cancer biomarkers market is anticipated to expand from USD 26.8 Billion in 2025 to USD 74.3 Billion by 2035, growing at a CAGR of 9.7%.
Growth is supported by:
Increasing demand for precise, early cancer detection.
Rapid advances in genomic, proteomic, and AI-driven biomarker platforms.
Expansion of liquid biopsy adoption, reducing reliance on invasive procedures.
Rising investments from governments and cancer foundations in national screening programs.
Biomarkers are becoming a cornerstone of personalized medicine, empowering clinicians to tailor treatments, monitor therapy response, and predict recurrence with higher accuracy.
Industry Developments
New Biomarker Launches (2024) - Multiple blood-based biomarkers adopted across North America, Europe, and Asia for less invasive cancer testing.
AI-Driven Digital Pathology - Tools enabling pathologists to extract and analyze biomarkers quickly, addressing workforce shortages in hospitals.
Funding Momentum - National screening programs and educational campaigns expanding biomarker adoption in oncology guidelines.
Market Dynamics
Drivers - Rising cancer incidence, demand for personalized medicine, integration of biomarkers into targeted therapy and companion diagnostics.
Restraints - Lack of testing standardization, limited reimbursement in some regions, and regulatory bottlenecks slowing assay approvals.
Opportunities - Liquid biopsy expansion, AI-enabled biomarker analysis, and multi-omics integration for more comprehensive tumor insights.
To know more about the Cancer Biomarkers Market - Download our Sample Report: https://marketgenics.co/download-report-sample/cancer-biomarkers-market-00931
Impact of Global Tariff Regulations
The cancer biomarkers market is sensitive to tariffs on diagnostic kits, reagents, and sequencing platforms:
High tariffs increase costs for hospitals and patients, especially in low- and middle-income regions.
Trade restrictions delay adoption of advanced biomarker tools.
Exemptions during public health campaigns improve access and encourage broader implementation of biomarker testing in national cancer programs.
Global tariff policies thus play a pivotal role in shaping affordability and adoption pathways for biomarker diagnostics.
Expansion of the Cancer Biomarkers Market
"Accelerating Growth Driven by Early Detection, Precision Medicine, and Technological Progress"
The market is experiencing strong momentum through:
Liquid biopsies for non-invasive early detection.
AI and machine learning for faster, more accurate biomarker data analysis.
Government funding and clinical guideline integration supporting biomarker adoption in mainstream oncology.
Cancer biomarkers are now central to therapy monitoring, drug discovery, and recurrence prediction, reinforcing their position in precision oncology ecosystems worldwide.
Get the Detailed Industry Analysis (including the Table of Contents, List of Figures, and List of Tables) - from the Cancer Biomarkers Market Research Report: https://marketgenics.co/press-releases/cancer-biomarkers-market-00931
Regional Analysis
North America - Largest market due to high cancer incidence, strong R&D, and early adoption of precision medicine. U.S. biotech firms and cancer centers lead biomarker innovations.
Europe - Rapid uptake in hospital systems and national screening programs, supported by strong regulatory guidance.
Asia Pacific - Fastest-growing region, with governments in India, China, and Japan funding early cancer detection initiatives. Growth challenged by test costs and workforce gaps in some nations.
Middle East & Africa - Early-stage adoption, with government initiatives beginning to integrate biomarkers into public health frameworks.
South America - Steady growth as healthcare systems improve access to advanced diagnostics.
Key Players in the Cancer Biomarkers Market
Abbott Laboratories, Agilent Technologies, Amgen Inc., AstraZeneca plc, Becton Dickinson & Company (BD), Bio-Rad Laboratories, Bristol-Myers Squibb, Eurofins Scientific, Exact Sciences Corporation, F. Hoffmann-La Roche Ltd., GE Healthcare, Guardant Health Inc., Illumina Inc., Merck & Co. Inc., Myriad Genetics Inc., PerkinElmer Inc., QIAGEN N.V., Siemens Healthineers AG, Sysmex Corporation, Thermo Fisher Scientific Inc., and other key players.
About Us
MarketGenics is a global market research and management consulting company empowering decision makers across healthcare, technology, and policy domains. Our mission is to deliver granular market intelligence combined with strategic foresight to accelerate sustainable growth.
We support clients across strategy development, product innovation, healthcare infrastructure, and digital transformation.
Contact:
Mr. Debashish Roy
MarketGenics India Pvt. Ltd.
800 N King Street, Suite 304 #4208, Wilmington, DE 19801, United States
USA: +1 (302) 303-2617
Email: sales@marketgenics.co
Website: https://marketgenics.co
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Cancer Biomarkers Market Anticipated to Exceed USD 74.3 Billion by 2035 here
News-ID: 4186133 • Views: …
More Releases from MarketGenics India Pvt. Ltd.
APAC Deepfake Detection Market Accelerates as Governments Tighten Digital Trust …
A Market Transforming How the World Verifies Reality
The global deepfake detection technology market, valued at USD 0.6 billion in 2025, is positioned to accelerate at a powerful 37.2% CAGR, reaching USD 15.1 billion by 2035.
This growth is driven by one undeniable truth:
Synthetic media is reshaping the threat landscape faster than humans can recognize it.
Deepfake detection technologies now determine:
How newsrooms verify breaking content
How financial institutions prevent identity-spoofing
How governments protect election integrity
How…
Travel & Expense Management Software Market Signals a Digital Pivot | AI, Cloud …
The Travel and Expense Management (TEM) Market Crossroads | A Sector Accelerating, Repricing Efficiency, and Redrawing the Corporate Spend Map
(Is TEM a Back-Office Tool-or the Operating System of the Next Enterprise Economy?)
For years, the travel and expense management software market lived in the administrative shadows-handed off to finance teams, constrained by spreadsheets, and dismissed as a routine cost-control tool. But the numbers now tell a radically different story.
In 2025, the…
Oilfield Equipment Market hits USD 116.2B in 2025 and grows to USD 156.5B by 203 …
Oilfield Equipment Market | The $156.5B Hardware Backbone of the Global Energy System
Every headline loves clean energy. Yet the global energy mix still demands a brutal truth: oil and gas remain the world's primary supply of heat, mobility, and petrochemicals - and the machines that drill, lift, complete, and produce hydrocarbons continue to define industrial capability.
That's why the Oilfield Equipment Market remains a strategic industry - not a relic.
In 2025,…
Machine Tools Market 2025-2035 | USD 109.9B Growth, CNC & Automation Trends
Machine Tools Market | The $109.9B Intelligence Engine of Global Manufacturing
Factories don't work without machine tools. They shape, cut, drill, grind, and define the physical world around us. Yet most end-products - cars, aircraft parts, electronics housings, surgical devices - never reveal the precision machinery behind them.
The Machine Tools Market is the invisible infrastructure that turns digital models into physical reality.
In 2025, the global Machine Tools Market stands at USD…
More Releases for Biomarker
Transformative Trends Impacting the Multiplex Biomarker Imaging Market Landscape …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
How Large Will the Multiplex Biomarker Imaging Market Size By 2025?
In recent times, the size of the multiplex biomarker imaging market has experienced significant growth. There is an expected rise from $0.49 billion in 2024 to $0.54 billion in 2025, with a compound annual growth rate (CAGR) of…
Blood-Based Biomarker Market Beyond the Needle: The Future of Diagnostics Lies i …
Blood-Based Biomarker Market worth $51.71 Bn by 2031 - Exclusive Report by InsightAce Analytic Pvt. Ltd.
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Blood-Based Biomarker Market - (By Type (Screening Biomarker, Diagnosis Biomarker, Others), By Disease (Cancer, Neurological Disorders, Others), By Application (Diagnostics, Drug Discovery, Personalized Medicine)), Trends, Industry Competition Analysis, Revenue and Forecast To 2031."
According to the latest research by InsightAce Analytic,…
Biomarker Discovery Outsourcing Services Market Biomarker Discovery Outsourcing: …
Biomarker Discovery Outsourcing Services Market to reach over USD 52.82 billion by the year 2031 - Exclusive Report by InsightAce Analytic
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Biomarker Discovery Outsourcing Services Market Size, Share & Trends Analysis Report By Type (Predictive Biomarkers, Prognostic Biomarkers, Safety Biomarkers And Surrogate Endpoints),
Therapeutic Area (Oncology, Neurology, Cardiology, Autoimmune Diseases), Discovery Phase (Biomarker Identification, Biomarker Validation,…
Biomarker and Companion Diagnostics Conference | Modeling Strategies for Biomark …
MarketsandMarkets presents the Immunobio Series, an extraordinary set of conferences taking place on 20-21 June 2024 in Boston, USA.
Register Now @ https://events.marketsandmarkets.com/2nd-annual-biomarker-and-companion-diagnostics-conference-usa-edition/register
MarketsandMarkets 5th Annual Biomarker and Companion Diagnostics Conference:
Immerse yourself in the realm of biomarkers at our flagship event, where industry leaders and experts converge to propel innovation in healthcare, diagnostics, and personalized medicine. This conference serves as a dynamic platform for collaboration, knowledge sharing, and exploration of cutting-edge…
Central Nervous System (CNS) Biomarkers Market Analysis Forecast 2023-2028 Globa …
The Central Nervous System (CNS) biomarkers market refers to the market for biomarkers used in the diagnosis, prognosis, and monitoring of diseases and disorders affecting the central nervous system. The central nervous system includes the brain and spinal cord, and disorders affecting this system can have significant impacts on an individual's health and well-being.
CNS biomarkers are measurable indicators that can provide information about the state of the central nervous system,…
Multiplex Biomarker Imaging Market - Advanced Solutions for Comprehensive Biomar …
Newark, New Castle, USA: The "Multiplex Biomarker Imaging Market" provides a value chain analysis of revenue for the anticipated period from 2023 to 2031. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors
Multiplex Biomarker Imaging Market: https://www.growthplusreports.com/report/multiplex-biomarker-imaging-market/8558
This latest report researches the industry structure,…
